Literature DB >> 23568998

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Joseph R Berger1, Allen J Aksamit, David B Clifford, Larry Davis, Igor J Koralnik, James J Sejvar, Russell Bartt, Eugene O Major, Avindra Nath.   

Abstract

OBJECTIVE: To establish criteria for the diagnosis of progressive multifocal leukoencephalopathy (PML).
METHODS: We reviewed available literature to identify various diagnostic criteria employed. Several search strategies employing the terms "progressive multifocal leukoencephalopathy" with or without "JC virus" were performed with PubMed, SCOPUS, and EMBASE search engines. The articles were reviewed by a committee of individuals with expertise in the disorder in order to determine the most useful applicable criteria.
RESULTS: A consensus statement was developed employing clinical, imaging, pathologic, and virologic evidence in support of the diagnosis of PML. Two separate pathways, histopathologic and clinical, for PML diagnosis are proposed. Diagnostic classification includes certain, probable, possible, and not PML.
CONCLUSION: Definitive diagnosis of PML requires neuropathologic demonstration of the typical histopathologic triad (demyelination, bizarre astrocytes, and enlarged oligodendroglial nuclei) coupled with the techniques to show the presence of JC virus. The presence of clinical and imaging manifestations consistent with the diagnosis and not better explained by other disorders coupled with the demonstration of JC virus by PCR in CSF is also considered diagnostic. Algorithms for establishing the diagnosis have been recommended.

Entities:  

Mesh:

Year:  2013        PMID: 23568998      PMCID: PMC3662270          DOI: 10.1212/WNL.0b013e31828c2fa1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  60 in total

1.  Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

Authors:  P Miralles; J Berenguer; C Lacruz; J Cosín; J C López; B Padilla; L Muñoz; D García-de-Viedma
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

2.  Reversible leukoencephalopathy in a patient with nucleoside analogue-associated mitochondrial DNA depletion and metabolic disease.

Authors:  Joseph A Church
Journal:  AIDS       Date:  2002-11-22       Impact factor: 4.177

3.  Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR.

Authors:  K Drews; T Bashir; K Dörries
Journal:  J Virol Methods       Date:  2000-01       Impact factor: 2.014

4.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

5.  Progressive multifocal leukoencephalopathy.

Authors:  B R Brooks; D L Walker
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

6.  Progressive multifocal leukoencephalopathy: its pathological features.

Authors:  E P Richardson; H D Webster
Journal:  Prog Clin Biol Res       Date:  1983

7.  Are astrocytes infected in progressive multifocal leukoencephalopathy (PML)?

Authors:  M Mázló; I Tariska
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

8.  Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features.

Authors:  J J Kepes; S M Chou; L W Price
Journal:  Neurology       Date:  1975-11       Impact factor: 9.910

Review 9.  The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.

Authors:  Paola Cinque; Igor J Koralnik; David B Clifford
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

10.  Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.

Authors:  R R Arthur; S Dagostin; K V Shah
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

View more
  200 in total

1.  A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Authors:  Nobuo Sanjo; Yurie Nose; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoshiki Sekijima; Hitoshi Aizawa; Toru Tanizawa; Takanori Yokota
Journal:  J Neurol       Date:  2018-12-03       Impact factor: 4.849

2.  Teaching NeuroImages: epilepsia partialis continua revealing PML after allogenic stem cell transplantation.

Authors:  Daniela Andriuta; Mélissa Tir; Bertille Perin; Philippe-Edouard Merle; Céline Bryer-Le Breton; Amandine Charbonnier; Jean-Marc Constans; Olivier Godefroy
Journal:  Neurology       Date:  2015-08-04       Impact factor: 9.910

3.  Eculizumab-related progressive multifocal leukoencephalopathy.

Authors:  Emilio Gómez-Cibeira; Yerko Ivanovic-Barbeito; Eduardo Gutiérrez-Martínez; Enrique Morales; Manuel Abradelo; Amaya Hilario; Ana Ramos; Juan Ruiz-Morales; Alberto Villarejo-Galende
Journal:  Neurology       Date:  2015-12-30       Impact factor: 9.910

Review 4.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

5.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

6.  Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Authors:  J Hodel; O Outteryck; S Verclytte; V Deramecourt; A Lacour; J-P Pruvo; P Vermersch; X Leclerc
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

Review 7.  Infection risk in patients on multiple sclerosis therapeutics.

Authors:  Eric M Williamson; Joseph R Berger
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 8.  Neurologic Complications of Human Immunodeficiency Virus Infection.

Authors:  Deanna Saylor
Journal:  Continuum (Minneap Minn)       Date:  2018-10

9.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.

Authors:  Rebekka Kurmann; Christian Weisstanner; Piotr Kardas; Hans H Hirsch; Roland Wiest; Bernhard Lämmle; Hansjakob Furrer; Renaud Du Pasquier; Claudio L Bassetti; Mathias Sturzenegger; Heinz Krestel
Journal:  J Neurovirol       Date:  2015-04-28       Impact factor: 2.643

Review 10.  Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.

Authors:  Valentina Felli; Alessandra Di Sibio; Monica Anselmi; Antonio Gennarelli; Patrizia Sucapane; Alessandra Splendiani; Alessia Catalucci; Carmine Marini; Massimo Gallucci
Journal:  Neuroradiol J       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.